» Articles » PMID: 37743445

RIP3 in Necroptosis: Underlying Contributions to Traumatic Brain Injury

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2023 Sep 24
PMID 37743445
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury (TBI) is a global public safety issue that poses a threat to death, characterized by high fatality rates, severe injuries and low recovery rates. There is growing evidence that necroptosis regulates the pathophysiological processes of a variety of diseases, particularly those affecting the central nervous system. Thus, moderate necroptosis inhibition may be helpful in the management of TBI. Receptor-interacting protein kinase (RIP) 3 is a key mediator in the necroptosis, and its absence helps restore the microenvironment at the injured site and improve cognitive impairment after TBI. In this report, we review different domains of RIP3, multiple analyses of necroptosis, and associations between necroptosis and TBI, RIP3, RIP1, and mixed lineage kinase domain-like. Next, we elucidate the potential involvement of RIP3 in TBI and highlight how RIP3 deficiency enhances neuronal function.

Citing Articles

Receptor-Interacting Protein Kinase 3 as a Serological Biomarker in Relation to Disease Severity and Delirium After Acute Pancreatitis: A Prospective Cohort Study.

Ye X, Li B, Xu F, Pan D, Wu J Int J Gen Med. 2024; 17:5309-5323.

PMID: 39569322 PMC: 11577434. DOI: 10.2147/IJGM.S488540.


"Biomarkers in severe traumatic brain injury: enhancing prognostic accuracy and therapeutic strategies".

Nadeem M, Shahzad U, Ahmed M, Khan M Neurosurg Rev. 2024; 47(1):608.

PMID: 39271500 DOI: 10.1007/s10143-024-02797-z.


A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury.

Zou S, Xu J, Yang W, Chen Z, Shan H, Liu J Neurosurg Rev. 2024; 47(1):433.

PMID: 39141133 DOI: 10.1007/s10143-024-02658-9.


Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases.

Han Y, Liu X, Jin M, Sun H, Kwon T Inflamm Res. 2023; 72(9):1839-1859.

PMID: 37725102 DOI: 10.1007/s00011-023-01790-4.

References
1.
Omer M, Posti J, Gissler M, Merikukka M, Barnighausen T, Wilson M . Birth order and pediatric traumatic brain injury. Sci Rep. 2022; 12(1):14451. PMC: 9402548. DOI: 10.1038/s41598-022-18742-3. View

2.
Narouiepour A, Ebrahimzadeh-Bideskan A, Rajabzadeh G, Gorji A, Negah S . Neural stem cell therapy in conjunction with curcumin loaded in niosomal nanoparticles enhanced recovery from traumatic brain injury. Sci Rep. 2022; 12(1):3572. PMC: 8897489. DOI: 10.1038/s41598-022-07367-1. View

3.
Hegdekar N, Lipinski M, Sarkar C . N-Acetyl-L-leucine improves functional recovery and attenuates cortical cell death and neuroinflammation after traumatic brain injury in mice. Sci Rep. 2021; 11(1):9249. PMC: 8084982. DOI: 10.1038/s41598-021-88693-8. View

4.
Nikolian V, Dekker S, Bambakidis T, Higgins G, Dennahy I, Georgoff P . Improvement of Blood-Brain Barrier Integrity in Traumatic Brain Injury and Hemorrhagic Shock Following Treatment With Valproic Acid and Fresh Frozen Plasma. Crit Care Med. 2017; 46(1):e59-e66. DOI: 10.1097/CCM.0000000000002800. View

5.
Jahan-Abad A, Negah S, Ravandi H, Ghasemi S, Borhani-Haghighi M, Stummer W . Human Neural Stem/Progenitor Cells Derived From Epileptic Human Brain in a Self-Assembling Peptide Nanoscaffold Improve Traumatic Brain Injury in Rats. Mol Neurobiol. 2018; 55(12):9122-9138. DOI: 10.1007/s12035-018-1050-8. View